Full planning consent achieved for GlaxoSmithKline’s Irvine Site



Great News!

The Farm Energy Company are pleased to announce that we have just achieved full planning consent at GlaxoSmithKline’s (GSK) Irvine site.

Our GSK planning consent covers 8MW of wind (2 Enercon E126 EP3  turbines with tip height of 150m) and 20MW of field scale solar. Once constructed, all of the power will be sold to GSK under a long term private wire PPA agreement.